Brief: Hemcheck Enters Conditional Agreement With Bio Vitos To Secure Continued Operations

Bio Vitos Pharma AB

08/02/2023 07:20

Feb 8 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * SAID ON TUESDAY ENTERS CONDITIONAL AGREEMENT WITH BIO
VITOS
MEDICAL LIMITED ON SECURING OF IP RIGHTS, CAPITAL, DISTRIBUTION
OF CURRENT BUSINESS
    * ENTERS AGREEMENT TO SECURE CO'S FUTURE FUNDING, CONTINUED
OPERATIONS 
    * SUBJECT TO EGM APPROVAL
    * IF APPROVED: CO'S CURRENT OPERATIONS WILL BE TRANSFERRED
TO A
WHOLLY OWNED SUBSIDIARY TO BE DISTRIBUTED TO CURRENT
SHAREHOLDERS 
    * CO ACQUIRES IP RIGHTS FOR USE OF IRON SUCCINATE FOR
PATIENT
TREATMENT IN CHINA, US, JAPAN, EU EXCL SWEDEN, DENMARK, NORWAY,
FINLAND
    * CO WILL RECEIVE A CAPITAL INJECTION OF SEK 4 MILLION
    * AS CONSIDERATION FOR IP RIGHTS, CAPITAL, DIRECTED SHARE
ISSUE OF
259,654,000 NEW SHARES WILL BE MADE TO BIO VITOS
    * BIO VITOS MAKES PAYMENT TO CO OF SEK 1.23 MILLION TO COVER
TRANSACTION COSTS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr8CsYs1
 Further company coverage:  HEMC.ST  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))